Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial. (2018)

First Author: Thwaites GE
Attributed to:  Other infectious diseases of global public health significance funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(17)32456-x

PubMed Identifier: 29249276

Publication URI: http://europepmc.org/abstract/MED/29249276

Type: Journal Article/Review

Volume: 391

Parent Publication: Lancet (London, England)

Issue: 10121

ISSN: 0140-6736